AHIP President and CEO Matt Eyles posed a question to Cost Plus Drugs CEO and co-founder Alex Oshmyansky, MD, PhD, on June 13 at the insurance trade group’s conference in Portland, Ore.: “Is there a role for Mark Cuban Cost Plus Drug Co. in terms of how you interact with hospitals going forward?”
Read the full post on Becker's Hospital Review - Healthcare News
